WPI 3629 (Hydromorphone Hydrochloride Extended-Release 8 mg)
Pill with imprint WPI 3629 is Brown, Round and has been identified as Hydromorphone Hydrochloride Extended-Release 8 mg. It is supplied by Watson Laboratories, Inc..
Hydromorphone is used in the treatment of chronic pain; pain; cough; anesthetic adjunct and belongs to the drug class narcotic analgesics. Risk cannot be ruled out during pregnancy. Hydromorphone 8 mg is classified as a Schedule 2 controlled substance under the Controlled Substance Act (CSA).
Images for WPI 3629
More about hydromorphone
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Patient Tips
- Drug Images
- Drug Interactions
- Compare Alternatives
- Pricing & Coupons
- 411 Reviews
- Drug class: narcotic analgesics
- FDA Alerts (10)
- Patient Information
- Hydromorphone injection
- Hydromorphone rectal
- Hydromorphone (Advanced Reading)
- Hydromorphone Injection (Advanced Reading)
- ... +4 more
Related treatment guides
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.